Notalgia Paresthetica Review : Update on Presentation, Pathophysiology, and Treatment
PURPOSE OF REVIEW: Notalgia paresthetica (NP) is a chronic cutaneous neuropathy primarily characterized by localized pruritus and associated dysesthesias, including sensations of pain, numbness, and tingling. The sensory neuropathy characteristic of NP is thought to result from spinal nerve entrapment caused by degenerative changes in the spine or musculoskeletal compression. This review summarizes the current medical literature with a focus on the past five years regarding NP, its pathophysiology, presentation, and current treatment options.
RECENT FINDINGS: Though treatments exist with varying efficacy, to date, there exists no definitive treatment for NP. Treatment options for NP are varied and range from topical and oral agents to interventional procedures and physical therapy. Of the treatments evaluated, topical capsaicin remains the most efficacious treatment for NP.
CONCLUSIONS: The lack of established treatment guidelines makes treating NP complicated as it dramatically affects patients' quality of life. Further research with larger sample sizes is needed to evaluate better the most effective treatment and dosing regimen for patients afflicted with NP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Clinics and practice - 13(2023), 1 vom: 19. Feb., Seite 315-325 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Robinson, Christopher [VerfasserIn] |
---|
Links: |
---|
Themen: |
Capsaicin |
---|
Anmerkungen: |
Date Revised 28.02.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/clinpract13010029 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353323810 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353323810 | ||
003 | DE-627 | ||
005 | 20231226055729.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/clinpract13010029 |2 doi | |
028 | 5 | 2 | |a pubmed24n1177.xml |
035 | |a (DE-627)NLM353323810 | ||
035 | |a (NLM)36826171 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Robinson, Christopher |e verfasserin |4 aut | |
245 | 1 | 0 | |a Notalgia Paresthetica Review |b Update on Presentation, Pathophysiology, and Treatment |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.02.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a PURPOSE OF REVIEW: Notalgia paresthetica (NP) is a chronic cutaneous neuropathy primarily characterized by localized pruritus and associated dysesthesias, including sensations of pain, numbness, and tingling. The sensory neuropathy characteristic of NP is thought to result from spinal nerve entrapment caused by degenerative changes in the spine or musculoskeletal compression. This review summarizes the current medical literature with a focus on the past five years regarding NP, its pathophysiology, presentation, and current treatment options | ||
520 | |a RECENT FINDINGS: Though treatments exist with varying efficacy, to date, there exists no definitive treatment for NP. Treatment options for NP are varied and range from topical and oral agents to interventional procedures and physical therapy. Of the treatments evaluated, topical capsaicin remains the most efficacious treatment for NP | ||
520 | |a CONCLUSIONS: The lack of established treatment guidelines makes treating NP complicated as it dramatically affects patients' quality of life. Further research with larger sample sizes is needed to evaluate better the most effective treatment and dosing regimen for patients afflicted with NP | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a capsaicin | |
650 | 4 | |a cutaneous neuropathy | |
650 | 4 | |a nostalgia paresthetica | |
650 | 4 | |a topical treatments | |
700 | 1 | |a Downs, Evan |e verfasserin |4 aut | |
700 | 1 | |a De la Caridad Gomez, Yanet |e verfasserin |4 aut | |
700 | 1 | |a Nduaguba, Chinonso |e verfasserin |4 aut | |
700 | 1 | |a Woolley, Parker |e verfasserin |4 aut | |
700 | 1 | |a Varrassi, Giustino |e verfasserin |4 aut | |
700 | 1 | |a Gill, Jatinder |e verfasserin |4 aut | |
700 | 1 | |a Simopoulos, Thomas T |e verfasserin |4 aut | |
700 | 1 | |a Viswanath, Omar |e verfasserin |4 aut | |
700 | 1 | |a Yazdi, Cyrus A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinics and practice |d 2011 |g 13(2023), 1 vom: 19. Feb., Seite 315-325 |w (DE-627)NLM237676680 |x 2039-7275 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:19 |g month:02 |g pages:315-325 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/clinpract13010029 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2023 |e 1 |b 19 |c 02 |h 315-325 |